Tána Ravingerová Selected Research

VULM 1457

12/2007

The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tána Ravingerová Research Topics

Disease

4	Ischemia 04/2010 - 05/2003
4	Infarction (Infarctions) 03/2010 - 07/2003
2	Reperfusion Injury 12/2009 - 12/2007
2	Myocardial Infarction 12/2007 - 03/2007
1	Necrosis 12/2007
1	Ventricular Fibrillation 12/2007
1	Diabetes Mellitus 12/2007
1	Shock 05/2003

Drug/Important Bio-Agent (IBA)

2	Streptozocin (Streptozotocin)FDA Link 12/2007 - 07/2003
1	PolyphenolsIBA 04/2010
1	QuercetinIBA 04/2010
1	FlavonoidsIBA 04/2010
1	Phosphotransferases (Kinase)IBA 03/2010
1	progelatinaseIBA 03/2010
1	WortmanninIBA 03/2010
1	EnzymesIBA 03/2010
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2010
1	Matrix Metalloproteinases (MMPs)IBA 03/2010
1	Simvastatin (Zocor)FDA LinkGeneric 12/2009
1	KATP ChannelsIBA 12/2009
1	triphenyltetrazoliumIBA 12/2009
1	mitochondrial K(ATP) channelIBA 12/2009
1	CholesterolIBA 12/2007
1	VULM 1457IBA 12/2007
1	Sterol O-AcyltransferaseIBA 12/2007
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2007
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 03/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2003
1	Protein Synthesis InhibitorsIBA 05/2003
1	CytokinesIBA 05/2003